Q4 2014 Holdings
Filed 2015-02-17 | 51 holdings | $131.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $85.7M | 7,050,356 | 65.1% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $25.4M | 1,555,355 | 19.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $9.0M | 2,474,076 | 6.8% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $7.0M | 597,363 | 5.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.0M | 17,600 | 1.5% |
| Biogen Idec Inc(BIIB) | COM | 09062X103 | $883.0K | 2,600 | 0.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $867.0K | 27,300 | 0.7% |
| Sangamo Biosciences Inc(SGMO)Call | COM | 800677106 | $91.6K | 6,000,000 | 0.1% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $82.1K | 6,700,000 | 0.1% |
| Regulus Therapeutics Inc | COM | 75915K101 | $76.1K | 4,742,911 | 0.1% |
| Dyax Corp | COM | 26746E103 | $69.5K | 4,945,697 | 0.1% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $53.1K | 3,350,449 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $46.4K | 506,122 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $40.0K | 2,428,571 | 0.0% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $31.8K | 1,000,000 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR)Call | COM | 00448Q201 | $30.6K | 2,500,000 | 0.0% |
| ZS Pharma Inc | COM | 98979G105 | $23.5K | 564,483 | 0.0% |
| Zafgen Inc | COM | 98885E103 | $22.6K | 732,960 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $22.4K | 1,399,423 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $20.2K | 970,600 | 0.0% |
| Novavax Inc | COM | 670002104 | $19.2K | 3,241,083 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $18.6K | 1,220,209 | 0.0% |
| Trevena Inc | COM | 89532E109 | $17.8K | 2,974,647 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $14.6K | 280,000 | 0.0% |
| Therapeuticsmd Inc | COM | 88338N107 | $14.3K | 3,211,132 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $13.9K | 310,554 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $13.0K | 1,250,000 | 0.0% |
| Tenax Therapeutics Inc | COM | 88032L100 | $10.3K | 2,670,300 | 0.0% |
| Bellicum Pharmaceuticals Inc | COM | 079481107 | $9.3K | 1,026,402 | 0.0% |
| Scynexis Inc | COM | 811292101 | $8.4K | 840,000 | 0.0% |
| Rockwell MED Inc | COM | 774374102 | $7.3K | 706,252 | 0.0% |
| Vical Inc | COM | 925602104 | $6.5K | 6,203,690 | 0.0% |
| CTI Biopharma Corp | COM | 12648L106 | $5.9K | 2,500,000 | 0.0% |
| Versartis Inc | COM | 92529L102 | $5.2K | 231,267 | 0.0% |
| Auris MED Hldg AG | COM | H03579101 | $3.7K | 940,000 | 0.0% |
| Biota Pharmaceutials Inc | COM | 090694100 | $3.1K | 1,378,770 | 0.0% |
| Ocera Therapeutics Inc | COM | 67552A108 | $2.7K | 417,476 | 0.0% |
| T2 Biosystems Inc | COM | 89853L104 | $2.7K | 138,002 | 0.0% |
| Wafergen Bio-Systems Inc | COM PAR$ | 93041P308 | $1.7K | 560,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $1.3K | 25,800 | 0.0% |
| Merrimack Pharmaceuticals Inc | COM | 590328100 | $1.3K | 116,400 | 0.0% |
| Newlink Genetics Corp | COM | 651511107 | $1.2K | 30,000 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.1K | 19,200 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $1.0K | 2,450 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $973 | 8,700 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $940 | 5,900 | 0.0% |
| Repligen Corp(RGEN) | COM | 759916109 | $891 | 45,000 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $838 | 59,200 | 0.0% |
| Celladon Corp | COM | 15117E107 | $799 | 40,900 | 0.0% |
| Kythera Biopharmaceuticals | COM | 501570105 | $789 | 22,750 | 0.0% |